Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vapreotide in Pancreas Surgery: A Double-Blind, Placebo-Controlled, Randomized Study of Vapreotide to Prevent Post-Surgical Complications in Patients Undergoing Elective Pancreatic Resection Grant Application Title: Vapreotide to Prevent Complications of Pancreatic Resection

NCT00014651 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00014651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00014651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vapreotide in Pancreas Surgery: A Double-Blind, Placebo-Controlled, Randomized Study of Vapreotide to Prevent Post-Surgical Complications in Patients Undergoing Elective Pancreatic Resection Grant Application Title: Vapreotide to Prevent Complications of Pancreatic Resection
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2001
Completion date
April 30, 2002
Enrollment
Not reported
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer, perioperative/postoperative complications